Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

× No keyword cloud information.

91 in total

1. Austrian Joint ÖGGH-ÖGIR-ÖGHO-ASSO position statement on the use of transarterial chemoembolization (TACE) in hepatocellular carcinoma.

Authors: Markus Peck-Radosavljevic; Wolfgang Sieghart; Claus Kölblinger; Markus Reiter; Martin Schindl; Gregor Ulbrich; Rudolf Steininger; Christian Müller; Rudolf Stauber; Maximilian Schöniger-Hekele; Manfred Gschwendtner; Christina Plank; Martin Funovics; Ivo Graziadei; Johannes Lammer; Thomas Gruenberger; Günther Gastl; Franz Karnel
Journal: Wien Klin Wochenschr Date: 2011-09-22 Impact factor: 1.704

2. Unresectable Hepatocellular Carcinoma Due to Portal Venous Thrombosis: Focal Stereotactic Body Radiation Therapy Can Promote Resectability.

Authors: Andrew Y Lee; Tianming Wu; Michael W Vannier; Giuliano Testa; Stanley L Liauw
Journal: J Gastrointest Cancer Date: 2012-09

3. Monitoring for post-transplant hepatocellular carcinoma recurrence.

Authors: Jorge Ortiz; Jennifer Danniel; Mariana Chavez; Giovanni Davogustto
Journal: HPB (Oxford) Date: 2012-03-11 Impact factor: 3.647

4. Decoding multifocal hepatocellular carcinoma: an opportune pursuit.

Authors: György Baffy
Journal: Hepatobiliary Surg Nutr Date: 2015-06 Impact factor: 7.293

Review 5. Personalized and precision medicine: integrating genomics into treatment decisions in gastrointestinal malignancies.

Authors: Trang H Au; Kai Wang; David Stenehjem; Ignacio Garrido-Laguna
Journal: J Gastrointest Oncol Date: 2017-06

6. Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib.

Authors: Olivier Mir; Romain Coriat; Pascaline Boudou-Rouquette; Stanislas Ropert; Jean-Philippe Durand; Anatole Cessot; Vincent Mallet; Philippe Sogni; Stanislas Chaussade; Stanislas Pol; François Goldwasser
Journal: Med Oncol Date: 2012-03-17 Impact factor: 3.064

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

1. Austrian Joint ÖGGH-ÖGIR-ÖGHO-ASSO position statement on the use of transarterial chemoembolization (TACE) in hepatocellular carcinoma.

2. Unresectable Hepatocellular Carcinoma Due to Portal Venous Thrombosis: Focal Stereotactic Body Radiation Therapy Can Promote Resectability.

3. Monitoring for post-transplant hepatocellular carcinoma recurrence.

4. Decoding multifocal hepatocellular carcinoma: an opportune pursuit.

Review 5. Personalized and precision medicine: integrating genomics into treatment decisions in gastrointestinal malignancies.

6. Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib.

7. Embolization of liver tumors: Past, present and future.

Review 8. Advances in managing hepatocellular carcinoma.

Review 9. Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectives.

10. Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma.